0001161697-23-000588.txt : 20231208 0001161697-23-000588.hdr.sgml : 20231208 20231208170009 ACCESSION NUMBER: 0001161697-23-000588 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231206 FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INGENITO GARY CENTRAL INDEX KEY: 0001279473 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 231476195 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 12-06-2023 X0508 4 2023-12-06 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001279473 INGENITO GARY 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Med. & Reg. Officer 0 Common stock, par value $0.001 per share 2023-12-06 4 M 0 50000 1.13 A 88367 D Common stock, par value $0.001 per share 2023-12-06 4 S 0 50000 14.02 D 38367 D Options to purchase common stock 1.13 2023-12-06 4 M 0 50000 0 D 2024-01-03 Common Stock 50000 974000 D Dr. Ingenito sold the shares on the open market for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.89 to $14.165 per share. Options vested in three annual tranches beginning on January 3, 2018. /s/ Gary Ingenito 2023-12-08